Répertoire de l'Université Alfonso X el Sabio

Treatment of moderate and severe adult chronic atopic dermatitis with narrow-band UVB and the combination of narrow-band UVB/UVA phototherapy

Afficher la notice abrégée

APA

Fernández Guarino, Montserrat & Aboin Gonzalez, Sonsoles & Barchino, Lucia & Velazquez, Diana & Arsuaga, Carmen & Lazaro, Pablo (2015 ) .Treatment of moderate and severe adult chronic atopic dermatitis with narrow-band UVB and the combination of narrow-band UVB/UVA phototherapy.

ISO 690

Fernández Guarino, Montserrat & Aboin Gonzalez, Sonsoles & Barchino, Lucia & Velazquez, Diana & Arsuaga, Carmen & Lazaro, Pablo. 2015 .Treatment of moderate and severe adult chronic atopic dermatitis with narrow-band UVB and the combination of narrow-band UVB/UVA phototherapy.

https://hdl.handle.net/20.500.12080/39632
dc.contributor.author Fernández Guarino, Montserrat
dc.contributor.author Aboin Gonzalez, Sonsoles
dc.contributor.author Barchino, Lucia
dc.contributor.author Velazquez, Diana
dc.contributor.author Arsuaga, Carmen
dc.contributor.author Lazaro, Pablo
dc.date.accessioned 2024-02-09T09:40:08Z
dc.date.available 2024-02-09T09:40:08Z
dc.date.created 2015
dc.date.issued 2015
dc.identifier.uri https://hdl.handle.net/20.500.12080/39632
dc.description.abstract The phototherapy is a safe and effective technique for the treatment of adult patients with atopic dermatitis (AD). The treatment of chronic forms of the disease is most often done with narrow band UVB (NB-UVB). There also exist effective phototherapy options against the AD. The aim of this study was to asses if the combination of NB-UVB with UVA was more effective than the treatment with only NB-UVB against adult chronic AD. We carried out a prospective and observational study. Adult patients with chronic AD with more than 50% of the total body surface area affected (TBSA) were included. The affected TBSA was calculated using the so-called ¿rule of nines.¿ Patients with a clearance rate >75% of the initial affected TBSA or complete clearance rate were considered as complete response (CR). An analogue scale from 0 to 10 was used to measure the improvement grade of the pruritus. The treatments were repeated three times a week. The initial doses of NB-UVB and UVA were determined by patient¿s phototype. The treatments were performed using a phototherapy booth (UV7002, Walmann, Villingen-Schwenningen, GermanyVR ) with TL01 and UVA fluorescent lamps. Statistical analysis was performed with SPSSVR (IBM, New York, NY) for Windows 21.0. A total of 26 patients with adult chronic AD were included in the study, 16 patients were treated with UVB-BE and 10 patients with the combined treatment option NB-UVB/UVA. The mean value of cumulative doses and the mean number of performed treatments were similar between both groups of patients (p> 0.05). The mean value of duration of response was significantly higher in the patients treated only with NB-UVB, 101 versus 6.8 months (p 0.05). No differences were observed for the patients that showed complete response (p 5 0.42) and in the analogue scale of pruritus (p> 0.005). In our study, the patients treated with the combination of NB-UVB and UVA were similar to the patient that were only treated with NB-UVB e. Further prospective and controlled studies have to be performed in order to determine the dosing regimens of phototherapy in adult patients with AD. KEYWORDS: atopic dermatitis, phototherapy, treatment es_ES
dc.format application/pdf es_ES
dc.language eng es_ES
dc.rights CC-BY es_ES
dc.rights.uri http://creativecommons.org/licenses/by/4.0/deed.es es_ES
dc.title Treatment of moderate and severe adult chronic atopic dermatitis with narrow-band UVB and the combination of narrow-band UVB/UVA phototherapy es_ES
dc.type info:eu-repo/semantics/article es_ES
dc.rights.accessrights info:eu-repo/semantics/restrictedAccess es_ES
dc.identifier.location N/A es_ES


Fichier(s) constituant ce document

Ce document figure dans la(les) collection(s) suivante(s)

Afficher la notice abrégée

CC-BY Excepté là où spécifié autrement, la license de ce document est décrite en tant que CC-BY

Chercher dans le dépôt


Parcourir

Mon compte

Social Media